1. Home
  2. AUPH vs PBI Comparison

AUPH vs PBI Comparison

Compare AUPH & PBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$16.96

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Pitney Bowes Inc.

PBI

Pitney Bowes Inc.

HOLD

Current Price

$16.86

Market Cap

2.3B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUPH
PBI
Founded
1993
1920
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Office Equipment/Supplies/Services
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.3B
IPO Year
2014
1994

Fundamental Metrics

Financial Performance
Metric
AUPH
PBI
Price
$16.96
$16.86
Analyst Decision
Buy
Hold
Analyst Count
4
3
Target Price
$17.25
$13.00
AVG Volume (30 Days)
858.1K
1.3M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
2.29%
EPS Growth
5075.00
175.00
EPS
0.53
0.75
Revenue
$283,055,000.00
$1,892,629,000.00
Revenue This Year
$17.54
N/A
Revenue Next Year
$15.74
N/A
P/E Ratio
$32.00
$23.09
Revenue Growth
20.38
N/A
52 Week Low
$10.34
$8.95
52 Week High
$19.25
$19.07

Technical Indicators

Market Signals
Indicator
AUPH
PBI
Relative Strength Index (RSI) 61.94 46.87
Support Level $15.65 $16.71
Resistance Level $17.80 $17.72
Average True Range (ATR) 0.42 0.44
MACD 0.06 0.02
Stochastic Oscillator 85.50 30.77

Price Performance

Historical Comparison
AUPH
PBI

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About PBI Pitney Bowes Inc.

Pitney Bowes Inc is a technology-driven company that provides SaaS shipping solutions, mailing innovation, and financial services to clients around the globe. The company's reportable segments are SendTech Solutions and Presort Services. SendTech Solutions includes the revenue and related expenses from physical and digital mailing and shipping technology solutions, financing, services, supplies and other applications to help simplify and save on the sending, tracking and receiving of letters, parcels and flats. Presort Services includes the revenue and related expenses from sortation services to qualify large volumes of First Class Mail, Marketing Mail and Marketing Mail Flats/Bound Printed Matter for postal work sharing discounts. It derives maximum revenue from SendTech Solutions.

Share on Social Networks: